Re: a drug that helped a girl talk

[Guest guest]

if you check the archives this is one of the drugs that has come up here

through some dans that gives me the creeps -this and giving our children herpes

medications to " try " that for speech on someone's theory as well. Even people

with Alzheimer disease have a choice to try natural as please research turmeric

and Alzheimer disease -here's just one study

http://www.annalsofian.org/article.asp?issn=0972-2327;year=2008;volume=11;issue=\

1;spage=13;epage=19;aulast=Mishra

As a matter of fact anyone considering or using the nutriiveda from

http://www.pursuitofresearch.org should read the above article as turmeric is

just one of the ayurvedic botanicals in the nutriiveda. And in addition to it

being all natural with " no known side effects " !!! (wait to you read the partial

list on the drug below) it contains other ayurvdic botanicals as well put

together by experts in this area medical doctors Dr. Deepak Chopra and Dr.

Simon.

The turmeric may explain why Alzheimer's is low in India

http://www.montefin.com/diet/health/spices/curry-turmeric-curcumin-alzheimers.ht\

ml

How dare they treat our children as guinea pigs giving them adult medications

which are off label for pediatrics as far as I know to " try " them?! There are

side effects to make one take notice even for the adults!!!! I mean has anyone

seen the commercials for any drug where typically the possible side effects are

a long list sounding far worse than the condition the drug was created for. Why

I'm starting to love ayurveda more and more!! For the one you brought up -just

search the name and side effects as google -some of the side effects could be

more common in children since after all they are little are including but not

limited to:

Side Effects by Body System

Cardiovascular

Cardiovascular side effects have included hypertension (4%). Cardiac failure,

angina pectoris, bradycardia, myocardial infarction, thrombophlebitis, atrial

fibrillation, hypotension, cardiac arrest, postural hypotension, pulmonary

embolism, and pulmonary edema have been reported during clinical trials, but no

direct correlation to memantine has been established. Atrioventricular block,

prolonged QT interval, supraventricular tachycardia, and tachycardia have been

reported subsequent to the worldwide marketing of memantine.

Nervous system

In a trial testing the use of memantine in MS patients with cognitive

impairment, nine out of nineteen patients reported a worsening of their

neurologic symptoms that deteriorated their quality of life. After stopping the

medication, the patients reverted to their baseline disability within a few

days.

Nervous system side effects have included dizziness (7%) and headache (6%).

Transient ischemic attack, cerebrovascular accident, vertigo, ataxia,

hypokinesia, paresthesia, convulsions, extrapyramidal disorder, hypertonia,

tremor, aphasia, hypoesthesia, abnormal coordination, hemiplegia, hyperkinesia,

involuntary muscle contractions, stupor, cerebral hemorrhage, neuralgia, ptosis,

and neuropathy have been reported during clinical trials, but these adverse

events may not be necessarily related to memantine. Carpal tunnel syndrome,

cerebral infarction, grand mal convulsions, intracranial hemorrhage, and

neuroleptic malignant syndrome have been reported subsequent to the worldwide

marketing of memantine.

Gastrointestinal

Gastrointestinal side effects have included constipation (5%) and vomiting (3%).

Gastroenteritis, diverticulitis, gastrointestinal hemorrhage, melena, and

esophageal ulceration have been reported during clinical trials, but no direct

correlation to memantine has been established. Colitis, dysphagia, gastritis,

ileus, acute pancreatitis, gastroesophageal reflux have been reported subsequent

to the worldwide marketing of memantine.

Musculoskeletal

Musculoskeletal side effects have included back pain (3%), bone fracture,

tardive dyskinesia, and dyskinesia.

Psychiatric

Psychiatric side effects have included confusion (6%), somnolence (3%), and

hallucination (3%). Aggressive reaction, delusion, personality disorder,

emotional lability, nervousness, sleep disorder, libido increased, psychosis,

amnesia, apathy, paranoid reaction, thinking abnormal, crying abnormal, appetite

increased, paroniria, delirium, depersonalization, neurosis, and suicide attempt

have been reported during clinical trials although not direct correlation to

memantine has been established,

Respiratory

Respiratory side effects have included coughing (4%) and dyspnea (2%).

Pneumonia, apnea, asthma, and hemoptysis have been reported during clinical

trials although these adverse events may not be necessarily related to

memantine.

Hematologic

Hematologic side effects reported during clinical trials have included anemia

and leukopenia, although no direct relationship to memantine has been

established. Postmarketing adverse events reporting from outside the U.S. have

included thrombocytopenia. Thrombocytopenia and hyperlipidemia have been

reported subsequent to the worldwide marketing of memantine.

Dermatologic

Dermatologic side effects reported during clinical trials have included rash,

skin ulceration, pruritus, cellulitis, eczema, dermatitis, erythematous rash,

alopecia and urticaria although these adverse events may not be necessarily

related to memantine.

s- syndrome has been reported subsequent to the worldwide marketing

of memantine. Postmarketing adverse events reporting from outside the U.S. have

included acne.

Metabolic

Metabolic side effects reported during clinical trials have included increased

alkaline phosphatase, decreased weight, dehydration, hyponatremia, and

aggravated diabetes mellitus although these adverse events may not be

necessarily related to memantine.

Ocular

Ocular side effects reported during clinical trials have included cataract,

conjunctivitis, macula lutea degeneration, decreased visual acuity, decreased

hearing, tinnitus, blepharitis, blurred vision, corneal opacity, glaucoma,

conjunctival hemorrhage, eye pain, retinal hemorrhage, xerophthalmia, diplopia,

abnormal lacrimation, myopia, and retinal detachment although these adverse

events may not be necessarily related to memantine.

Genitourinary

Genitourinary side effects reported during clinical trials have included

frequent micturition, dysuria, hematuria, and urinary retention, although these

adverse events may not be necessarily related to memantine treatment.

Postmarketing adverse events reporting outside the U.S. have included impotence.

Other

Other side effects including claudication, chest pain, malaise, restlessness,

and sudden death have been reported subsequent to the worldwide marketing of

memantine.

Hepatic

Hepatic side effects have included hepatic failure, which was reported

subsequent to the worldwide marketing of memantine.

Renal

Renal side effects have included acute renal failure, which has been reported

subsequent to the worldwide marketing of memantine.

http://www.drugs.com/sfx/namenda-side-effects.html

Are you kidding me? I wouldn't give this to my dog if he had Alzheimer's!!!

=====